This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Oncology

18
In vitro advances in predicting resistance to PARP inhibitors for BRCA1/2 mutations
In vitro advances in predicting resistance to PARP inhibitors for BRCA1/2 mutations
Read more
Non-invasive targeted procedure for liver cancer to be available on NHS
Non-invasive targeted procedure for liver cancer to be available on NHS
Read more
Gut biomarkers identified to improve detection and targeted treatment of GI disorders
Gut biomarkers identified to improve detection and targeted treatment of GI disorders
Read more
Helping breast cancer patients get the right support, at the right time
Helping breast cancer patients get the right support, at the right time
Read more
Rollout of ‘cutting-edge’ radiotherapy machines set to reduce waiting times in England
Rollout of ‘cutting-edge’ radiotherapy machines set to reduce waiting times in England
Read more
Supplemental scans improve cancer detection in women with dense breasts
Supplemental scans improve cancer detection in women with dense breasts
Read more
‘Game-changing’ assay for ultra-rapid intraoperative diagnosis of CNS tumours
‘Game-changing’ assay for ultra-rapid intraoperative diagnosis of CNS tumours
Read more
The histopathology dashboard helping clinicians translate AI research into oncology practice
The histopathology dashboard helping clinicians translate AI research into oncology practice
Read more
Can dietary fibre mitigate prostate cancer radiotherapy side effects?
Can dietary fibre mitigate prostate cancer radiotherapy side effects?
Read more
Transforming breast cancer care with pre-operative genetic testing: Pre-DX trial insights
Transforming breast cancer care with pre-operative genetic testing: Pre-DX trial insights
Read more
Expediting genomic testing pathways: analysis of the UKLCC lung cancer report
Expediting genomic testing pathways: analysis of the UKLCC lung cancer report
Read more
Saliva test more accurate than PSA level or MRI for prostate cancer risk, study suggests
Saliva test more accurate than PSA level or MRI for prostate cancer risk, study suggests
Read more
Scheduled appointments superior to open invitations for lung cancer screening attendance
Scheduled appointments superior to open invitations for lung cancer screening attendance
Read more
Red flag colorectal cancer symptoms often mistaken for chronic condition medication side effects
Red flag colorectal cancer symptoms often mistaken for chronic condition medication side effects
Read more
Understanding patient experiences of urgent and emergency cancer care
Understanding patient experiences of urgent and emergency cancer care
Read more
More effective immunotherapies possible as aspirin’s anti-metastatic mechanism discovered
More effective immunotherapies possible as aspirin’s anti-metastatic mechanism discovered
Read more
IgE therapy shows promise for treatment-resistant breast and ovarian cancers
IgE therapy shows promise for treatment-resistant breast and ovarian cancers
Read more
Improving treatment pathways in muscle-invasive bladder cancer
Improving treatment pathways in muscle-invasive bladder cancer
Read more

Popular articles

Genetic link between pancreatitis risk and GLP-1 medicines to be investigated
Setting a new standard in blood-borne virus testing and detection in the ED
Further progress in predicting methotrexate response in JIA
Research, consensus and progress in fighting TB: ESCMID Global insights
Significant strain on paediatric workforce poses serious risks to child health, RCPCH warns as it calls for action



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x